# Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors

> **NCT00610389** · PHASE2 · UNKNOWN · sponsor: **Clinica Universidad de Navarra, Universidad de Navarra** · enrollment: 27 (estimated)

## Conditions studied

- Renal Cell Carcinoma
- Melanoma
- Carcinoma, Hepatocellular

## Interventions

- **BIOLOGICAL:** immunotherapy with dendritic cells

## Key facts

- **NCT ID:** NCT00610389
- **Lead sponsor:** Clinica Universidad de Navarra, Universidad de Navarra
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-02
- **Primary completion:** 2010-04
- **Final completion:** 2010-12
- **Target enrollment:** 27 (ESTIMATED)
- **Last updated:** 2010-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00610389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00610389, "Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00610389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*